-
Zdravljenje malignega melanoma žilnice z brahiterapijo (Ru-106) - 14-letne izkušnje = Brachytherapy (Ru-106) for choroidal melanoma - our experience of 14 yearsNovak-Andrejčič, Katrina ...Background. For many years, malignant melanoma of the choroid was treated withprompt enucleation. Recently several eye preserving methods have been developed. The aim of our study was to report on ... the therapeutic results in patients with primary choroidal melanoma treated with ruthenium-106 brachytherapy. Methods. A retrospective chart review of 65 patients treated with ruthenium-106 brachytherapy for choroidal melanoma from 1986 to 1997 was performed. The patients were 22 to 78 years old (mean 54.5 years). The height of the tumors was within the range of 1.5 to 7.1 mm (mean 4.7mm). The mean dose to the apex of the tumor was 100 Gy. Mean follow-up period was 90.6 months (range 22 to 169 months). Fundus photography, diagnostic ultrasound andbest corrected visual acuity were performed during each examination before and after radiation. Results.12 (18.4%) patients died from metastatic spread and 2 from other causes. Complete tumor regression occurred in 12 (18.4%) patients. Tumor regression was partial in 31 (47.7%) patients. Enucleation because of tumor growth was performed in 11(16.9%) patients and in 2 for otherreasons. 19 (30%) eyes retained visual acuity better than 0.5 and 49% of patients had visual acuity better than 0.1. Conclusions. Ruthenium brachytherapy has proved to be an effective conservative treatment for uveal melanomas thinner than 7mm. The present results correspond well with data in the literature. Visual outcome correlates with tumor location.Vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 71, supl. 2, apr. 2002, str. II-67-II-70)Vrsta gradiva - članek, sestavni delLeto - 2002Jezik - slovenskiCOBISS.SI-ID - 14711769
Avtor
Novak-Andrejčič, Katrina |
Logar, Primož |
Brovet-Zupančič, Irena-Hedvika, 1944-2023 |
Jančar, Boris
Teme
Choroid neoplasms |
Radiotherapy |
Melanoma |
Brachytherapy |
Visual acuity |
Treatment outcome |
Brahiterapija |
Horioidea, novotvorbe |
Melanom |
Izid zdravljenja |
Vid, ostrina |
oftalmologija |
melanom |
žilnica |
zdravljenje
vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 71, supl. 2, apr. 2002, str. II-67-II-70)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Novak-Andrejčič, Katrina | 18630 |
Brovet-Zupančič, Irena-Hedvika, 1944-2023 | 08902 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi